Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding.
Waldera-Lupa DM, Etemad-Parishanzadeh O, Brocksieper M, Kirchgaessler N, Seidel S, Kowalski T, Montesinos-Rongen M, Deckert M, Schlegel U, Stühler K. Waldera-Lupa DM, et al. Among authors: schlegel u. Oncotarget. 2017 Nov 24;8(66):110118-110132. doi: 10.18632/oncotarget.22654. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299134 Free PMC article.
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U. Pels H, et al. Among authors: schlegel u. J Clin Oncol. 2003 Dec 15;21(24):4489-95. doi: 10.1200/JCO.2003.04.056. Epub 2003 Nov 3. J Clin Oncol. 2003. PMID: 14597744 Clinical Trial.
VH gene analysis of primary CNS lymphomas.
Pels H, Montesinos-Rongen M, Schaller C, Schlegel U, Schmidt-Wolf IG, Wiestler OD, Deckert M. Pels H, et al. Among authors: schlegel u. J Neurol Sci. 2005 Feb 15;228(2):143-7. doi: 10.1016/j.jns.2004.11.038. Epub 2004 Dec 19. J Neurol Sci. 2005. PMID: 15694195
Primary central nervous system lymphoma.
Pels H, Schlegel U. Pels H, et al. Among authors: schlegel u. Curr Treat Options Neurol. 2006 Jul;8(4):346-57. doi: 10.1007/s11940-006-0024-8. Curr Treat Options Neurol. 2006. PMID: 16942677
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
Courts C, Montesinos-Rongen M, Martin-Subero JI, Brunn A, Siemer D, Zühlke-Jenisch R, Pels H, Jürgens A, Schlegel U, Schmidt-Wolf IG, Schaller C, Reifenberger G, Sabel M, Warnecke-Eberz U, Wiestler OD, Küppers R, Siebert R, Deckert M. Courts C, et al. Among authors: schlegel u. J Neuropathol Exp Neurol. 2007 Mar;66(3):230-7. doi: 10.1097/01.jnen.0000248553.45456.96. J Neuropathol Exp Neurol. 2007. PMID: 17356384
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.
Pels H, Juergens A, Glasmacher A, Schulz H, Engert A, Linnebank M, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Lamprecht M, Hau P, Deckert M, Fimmers R, Bangard C, Schmidt-Wolf IG, Schlegel U. Pels H, et al. Among authors: schlegel u. J Neurooncol. 2009 Feb;91(3):299-305. doi: 10.1007/s11060-008-9712-4. Epub 2008 Oct 18. J Neurooncol. 2009. PMID: 18931887 Free article. Clinical Trial.
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma.
Pels H, Juergens A, Schirgens I, Glasmacher A, Schulz H, Engert A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Deckert M, Fimmers R, Urbach H, Schmidt-Wolf IG, Schlegel U. Pels H, et al. Among authors: schlegel u. Neuro Oncol. 2010 Jul;12(7):720-4. doi: 10.1093/neuonc/noq010. Epub 2010 Feb 16. Neuro Oncol. 2010. PMID: 20159882 Free PMC article. Clinical Trial.
306 results